| [1] |
Baird PN, Saw SM, Lanca C, Guggenheim JA, Smith III EL, et al. 2020. Myopia. |
| [2] |
Liang J, Pu Y, Chen J, Liu M, Ouyang B, et al. 2025. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. |
| [3] |
Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, et al. 2016. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. |
| [4] |
Morgan IG, Jan CL. 2022. China turns to school reform to control the myopia epidemic: a narrative review. |
| [5] |
Yotsukura E, Torii H, Inokuchi M, Tokumura M, Uchino M, et al. 2019. Current prevalence of myopia and association of myopia with environmental factors among schoolchildren in Japan. |
| [6] |
Karuppiah V, Wong L, Tay V, Ge X, Kang LL. 2021. School-based programme to address childhood myopia in Singapore. |
| [7] |
Tsai TH, Liu YL, Ma IH, Su CC, Lin CW, et al. 2021. Evolution of the prevalence of myopia among Taiwanese schoolchildren: a review of survey data from 1983 through 2017. |
| [8] |
Kim H, Seo JS, Yoo WS, Kim GN, Kim RB, et al. 2020. Factors associated with myopia in Korean children: Korea National Health and nutrition examination survey 2016–2017 (KNHANES VII). |
| [9] |
World Society of Paediatric Ophthalmology and Strabismus. 2023. Myopia Consensus Statement. www.wspos.org/swdcore/uploads/WSPOS-Myopia-Consensus-Statement-2023-1.pdf (Accessed on 10-8-2024) |
| [10] |
Chen X, Wu M, Yu C, Ohlendorf A, Li W, et al. 2025. Efficacy of cylindrical annular refractive elements (CARE) spectacle lenses in slowing myopia progression over 2 years. |
| [11] |
Bao J, Huang Y, Li X, Yang A, Zhou F, et al. 2022. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. |
| [12] |
Lam CSY, Tang WC, Tse DYY, Lee RPK, Chun RKM, et al. 2020. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. |
| [13] |
Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, et al. 2022. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. |
| [14] |
Wolffsohn JS, Whayeb Y, Logan NS, Weng R, the International Myopia Institute Ambassador Group. 2023. IMI—global trends in myopia management attitudes and strategies in clinical practice—2022 update. |
| [15] |
Gifford KL, Richdale K, Kang P, Aller TA, Lam CS, et al. 2019. IMI - clinical management guidelines report. |
| [16] |
O'Donoghue L, McClelland JF, Logan NS, Rudnicka AR, Owen CG, et al. 2010. Refractive error and visual impairment in school children in Northern Ireland. |
| [17] |
Chamberlain P, Bradley A, Arumugam B, Hammond D, McNally J, et al. 2022. Long-term effect of dual-focus contact lenses on myopia progression in children: a 6-year multicenter clinical trial. |
| [18] |
Walline JJ, Jones LA, Sinnott L, Chitkara M, Coffey B, et al. 2009. Randomized trial of the effect of contact lens wear on self-perception in children. |
| [19] |
CooperVision, Inc. 2019. MiSight 1 Day (omafilcon A) soft (hydrophilic) contact lenses for daily wear. New York, NY: CooperVision, Inc. pp. 1−7 www.accessdata.fda.gov/cdrh_docs/pdf18/P180035C.pdf |
| [20] |
Mohd-Ali B, Low YC, Mohamad Shahimin M, Arif N, Abdul-Hamid H, et al. 2023. Comparison of vision-related quality of life between wearing Orthokeratology lenses and spectacles in myopic children living in Kuala Lumpur. |
| [21] |
McAlinden C, Lipson M. 2018. Orthokeratology and contact lens quality of life questionnaire (OCL-QoL). |
| [22] |
Donovan L, Sankaridurg P, Ho A, Naduvilath T, Smith EL 3rd, et al. 2012. Myopia progression rates in urban children wearing single-vision spectacles. |
| [23] |
Morgan PB, McCullough SJ, Saunders KJ. 2020. Estimation of ocular axial length from conventional optometric measures. |
| [24] |
Martínez-Pérez C, Santodomingo-Rubido J, Villa-Collar C, Whayeb Y, Wolffsohn JS. 2025. European trends in attitudes and strategies for myopia management in clinical practice. |
| [25] |
Saxena R, Dhiman R, Gupta V, Phuljhele S, Mahajan A, et al. 2023. Prevention and management of childhood progressive myopia: National consensus guidelines. |
| [26] |
Mountford J, Cho P, Chui WS. 2005. Is fluorescein pattern analysis a valid method of assessing the accuracy of reverse geometry lenses for orthokeratology? |
| [27] |
Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, et al. 2019. A 3-year randomized clinical trial of MiSight lenses for myopia control. |
| [28] |
Hu Y, Ding X, Guo X, Chen Y, Zhang J, et al. 2020. Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort. |
| [29] |
Hsu CC, Huang N, Lin PY, Fang SY, Tsai DC, et al. 2017. Risk factors for myopia progression in second-grade primary school children in Taipei: a population-based cohort study. |
| [30] |
Chua SYL, Sabanayagam C, Cheung YB, Chia A, Valenzuela RK, et al. 2016. Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children. |
| [31] |
Brennan NA, Shamp W, Maynes E, Cheng X, Bullimore MA. 2024. Influence of age and race on axial elongation in myopic children: a systematic review and meta-regression. |
| [32] |
Mutti DO, Hayes JR, Mitchell GL, Jones LA, Moeschberger ML, et al. 2007. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. |
| [33] |
Saw SM, Chua WH, Gazzard G, Koh D, Tan DTH, et al. 2005. Eye growth changes in myopic children in Singapore. |
| [34] |
Chamberlain P, Lazon de la Jara P, Arumugam B, Bullimore MA. 2021. Axial length targets for myopia control. |
| [35] |
Yii FS. 2023. Emmetropic eye growth in East Asians and non-East Asians. |
| [36] |
Kaymak H, Graff B, Neller K, Langenbucher A, Seitz B, et al. 2021. Myopia treatment and prophylaxis with defocus incorporated multiple segments spectacle lenses. |
| [37] |
Hammond D, Chamberlain P, Arumugam B, Bradley A. 2022. Eye growth of children undergoing myopia control treatment compared with emmetropic eye growth. |
| [38] |
Bullimore MA, Saunders KJ, Baraas RC, Berntsen DA, Chen Z, et al. 2025. IMI—interventions for controlling myopia onset and progression 2025. |
| [39] |
Zadnik K, Schulman E, Flitcroft I, Fogt JS, Blumenfeld LC, et al. 2023. Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial. |
| [40] |
Erdinest N, London N, Levinger N, Morad Y. 2021. Myopia control with combination low-dose atropine and peripheral defocus soft contact lenses: a case series. |
| [41] |
Erdinest N, London N, Lavy I, Landau D, Ben Ephraim Noyman D, et al. 2022. Low-concentration atropine monotherapy vs. combined with MiSight 1 day contact lenses for myopia management. |
| [42] |
Medghalchi A, Behboudi H, Akbari M, Moghadam RS, Kazemnejad E, et al. 2023. The preventive role of atropine eye drops on myopia progression: a double-blind randomized clinical trial. |
| [43] |
Tong L, Huang XL, Koh ALT, Zhang X, Tan DTH, et al. 2009. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. |